Rafferty Asset Management, LLC Mirum Pharmaceuticals, Inc. Transaction History
Rafferty Asset Management, LLC
- $28.9 Billion
- Q3 2024
A detailed history of Rafferty Asset Management, LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 85,457 shares of MIRM stock, worth $3.57 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
85,457
Previous 68,858
24.11%
Holding current value
$3.57 Million
Previous $2.35 Million
41.55%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding MIRM
# of Institutions
190Shares Held
54MCall Options Held
177KPut Options Held
167K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$274 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.48MShares$187 Million0.09% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.45MShares$144 Million2.37% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$135 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.08MShares$128 Million3.81% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.53B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...